A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/37 (2006.01) A61K 47/48 (2006.01) C07K 14/755 (2006.01)
Patent
CA 2704234
The present invention provides novel methods of increasing the survival of a coagulation protein by inhibiting the interaction with a clearance receptor. The invention also provides methods of preparing compositions that inhibit coagulation protein clearance receptors. Conjugated coagulation proteins, including compositions and formulations thereof, are also provided by the present invention.
L'invention concerne de nouveaux procédés permettant d'augmenter la survie d'une protéine de coagulation en inhibant l'interaction avec un récepteur de clairance. L'invention concerne également des procédés de préparation de compositions qui inhibent les récepteurs de clairance des protéines de coagulation. L'invention concerne également des protéines de coagulation conjuguées, ainsi que des compositions et des formulations les contenant.
Schwarz Hans-Peter
Turecek Peter
Baxter Healthcare S.a.
Baxter International Inc.
Sim & Mcburney
LandOfFree
Modified recombinant factor viii and von willebrand factor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified recombinant factor viii and von willebrand factor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified recombinant factor viii and von willebrand factor... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1486443